Association of class 1 and 2 integrons with multidrug-resistant Acinetobacter baumannii international clones and Acinetobacter nosocomialis isolates

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 1, 2015, Pages 698-701

  Martins, Natacha ^a   Picão, Renata Cristina ^a   Adams Sapper, Sheila ^b   Riley, Lee W ^b   Moreira, Beatriz Meurer ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METALLO BETA LACTAMASE; ANTIINFECTIVE AGENT;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER NOSOCOMIALIS; AMPLICON; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIUM ISOLATE; CLONE; COHORT ANALYSIS; COMPUTER MODEL; CROSS INFECTION; GENE CASSETTE; INTEGRON; MULTIDRUG RESISTANCE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; RANDOM AMPLIFIED POLYMORPHIC DNA; SOUTH AND CENTRAL AMERICA; ACINETOBACTER INFECTIONS; BACTERIAL GENE; DRUG EFFECTS; GENETICS; GENOTYPE; HUMAN; MICROBIOLOGY;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; GENOTYPE; HUMANS; INTEGRONS;

EID: 84920149808     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02415-14     Document Type: Article

References (22)

1. Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY, Leblebicioglu H, Abu Khader I, Miranda Novales MG, Berba R, Ramírez Wong FM, Barkat A, Pino OR, Dueñas L, Mitrev Z, Bijie H, Gurskis V, Kanj SS, Mapp T, Hidalgo RF, Ben Jaballah N, Raka L, Gikas A, Ahmed A, Thu LTA, Guzmán Siritt ME, INICC Members. 2010. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003 to 2008, issued June 2009. Am J Infect Control 38:95-104.e2. http://dx.doi.org/10.1016/j.ajic.2009.12.004.
2. Lee Y-C, Huang Y-T, Tan C-K, Kuo Y-W, Liao C-H, Lee P-I, Hsueh P-R. 2011. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes. J Antimicrob. Chemother 66:1839-1846. http://dx.doi.org/10.1093/jac/dkr200.
3. Karah N, Giske CG, Sundsfjord A, Samuelsen Ø. 2011. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages. Microb Drug Resist 17:545-549. http: //dx.doi.org/10.1089/mdr.2011.0089.
4. Karah N, Sundsfjord A, Towner K, Samuelsen O. 2012. Insights into the global molecular epidemiology of carbapenem nonsusceptible clones of Acinetobacter baumannii. Drug Resist Updat 15:237-247. http://dx.doi.org/10.1016/j.drup.2012.06.001.
5. Ramírez MS, Morales A, Vilacoba E, Márquez C, Centrón D. 2012. Class 2 integrons dissemination among multidrug resistance (MDR) clones of Acinetobacter baumannii. Curr Microbiol 64:290-293. http://dx.doi.org/10.1007/s00284-011-0068-1.
6. Pagano M, Martins AF, Machado ABMP, Barin J, Barth AL. 2013. Carbapenem-susceptible Acinetobacter baumannii carrying the ISAba1 upstream blaOXA-51-like gene in Porto Alegre, southern Brazil. Epidemiol Infect 141:330-333. http://dx.doi.org/10.1017/S095026881200074X.
7. Ramírez MS, Piñeiro S, Centrón D. 2010. Novel insights about class 2 integrons from experimental and genomic epidemiology. Antimicrob Agents Chemother 54:699-706. http://dx.doi.org/10.1128/AAC.01392-08.
8. Hansson K, Sundstrom L, Pelletier A, Roy PH. 2002. IntI2 integron integrase in Tn7. J Bacteriol 184:1712-1721. http://dx.doi.org/10.1128/JB.184.6.1712-1721.2002.
9. Girão VBDC, Martins N, Cacci LC, Coelho-Souza T, Nouer SA, Riley LW, Moreira BM. 2013. Dissemination of Acinetobacter nosocomialis clone among critically ill patients and the environment. J Clin Microbiol 51:2707-2709. http://dx.doi.org/10.1128/JCM.00915-13.
10. Martins N, Martins IS, de Freitas WV, de Matos JA, Girão VBDC, Coelho-Souza T, Maralhães ACDG, Cacci LC, de Figueiredo MP, Dias RCS, Costa-Lourenço APR, Ferreira ALP, Dalla-Costa L, Nouér SA, Santoro-Lopes G, Riley LW, Moreira BM. 2013. Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients. Microb Drug Resist 19: 216-223. http://dx.doi.org/10.1089/mdr.2012.0174.
11. Xu X, Kong F, Cheng X, Yan B, Du X, Gai J, Ai H, Shi L, Iredell J. 2008. Integron gene cassettes in Acinetobacter spp. strains from South China. Int J Antimicrob Agents 32:441-445. http://dx.doi.org/10.1016/j.ijantimicag.2008.05.014.
12. White PA, McIver CJ, Rawlinson WD. 2001. Integrons and gene cassettes in the Enterobacteriaceae. Antimicrob Agents Chemother 45:2658-2661. http://dx.doi.org/10.1128/AAC.45.9.2658-2661.2001.
13. Ramírez MS, Quiroga C, Centrón D. 2005. Novel rearrangement of a class 2 integron in two nonepidemiologically related isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 49:5179-5181. http://dx.doi.org/10.1128/AAC.49.12.5179-5181.2005.
14. Stietz MS, Ramírez MS, Vilacoba E, Merkier AK, Limansky AS, Centrón D, Catalano M. 2013. Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III. Infect Genet Evol 14:294-301. http://dx.doi.org/10.1016/j.meegid.2012.12.020.
15. Clímaco EC, de Oliveira ML, Pitondo-Silva A, Oliveira MG, Medeiros M, Lincopan N, da Costa Darini AL. 2013. Clonal complexes 104, 109 and 113 playing a major role in the dissemination of OXAcarbapenemase- producing Acinetobacter baumannii in southeast Brazil. Infect Genet Evol 19:127-133. http://dx.doi.org/10.1016/j.meegid.2013.06.024.
16. Turton JF, Kaufmann ME, Glover J, Coelho JM, Warner M, Pike R, Pitt TL. 2005. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J Clin Microbiol 43: 3074-3082. http://dx.doi.org/10.1128/JCM.43.7.3074-3082.2005.
17. Ramírez MS, Stietz MS, Vilacoba E, Jeric P, Limansky AS, Catalano M, Centrón D. 2011. Increasing frequency of class 1 and 2 integrons in multidrug- resistant clones of Acinetobacter baumannii reveals the need for continuous molecular surveillance. Int J Antimicrob Agents 37:175-177. http://dx.doi.org/10.1016/j.ijantimicag.2010.10.006.
18. Taherikalani M, Maleki A, Sadeghifard N, Mohammadzadeh D, Soroush S, Asadollahi P, Asadollahi K, Emaneini M. 2011. Dissemination of class 1, 2 and 3 integrons among different multidrug resistant isolates of Acinetobacter baumannii in Tehran hospitals, Iran. Pol J Microbiol 60: 169-174.
19. Liu C-C, Tang CY, Chang K-C, Kuo H-Y, Liou M-L. 2014. A comparative study of class 1 integrons in Acinetobacter baumannii. Gene 544:75-82. http://dx.doi.org/10.1016/j.gene.2014.04.047.
20. Yamamoto M, Nagao M, Matsumura Y, Matsushima A, Ito Y, Takakura S, Ichiyama S. 2011. Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among Acinetobacter species in Japan. J Antimicrob. Chemother 66:2480-2483. http://dx.doi.org/10.1093/jac/dkr336.
21. Kim Y, Roh KH, Lee Y, Chung H-S, Yum JH, Yong D, Lee K, Chong Y. 2013. Clonal change of blaSIM-1-carrying Acinetobacter spp. from 2003 to 2008 in the hospital where it was initially discovered. Microb Drug Resist 19:37-41. http://dx.doi.org/10.1089/mdr.2012.0038.
22. Fonseca ÉL, Freitas FDS, Scheidegger ÉMD, Jacinto T, Vicente ACP. 2011. Class 2 integrons in multidrug-resistant Acinetobacter baumannii circulating in different Brazilian geographic regions. Int J Antimicrob Agents 38:95-96. http://dx.doi.org/10.1016/j.ijantimicag.2011.03.013.